Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance

Go back to Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
LIGAND PHARMA (NASDAQ: LGND) Delayed: 284.47 -4.78 (1.65%)
Previous Close $289.25    52 Week High $139.79 
Open $291.48    52 Week Low $82.07 
Day High $294.00    P/E 661.56 
Day Low $283.77    EPS $0.43 
Volume 261,166